(Q40846560)

24 September 2017

1 reference

title

Pediatric antifungal therapy (English)

1 reference

24 September 2017

Friedlander SF

1

1 reference

24 September 2017

Suarez S

series ordinal

2

1 reference

24 September 2017

publication date

1 July 1998

1 reference

24 September 2017

1 reference

24 September 2017

volume

16

1 reference

24 September 2017

issue

3

1 reference

24 September 2017

page(s)

527-537

1 reference

Topical terbinafine and clotrimazole in interdigital tinea pedis: a multicenter comparison of cure and relapse rates with 1- and 4-week treatment regimens.

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970250-3

7 January 2021

Antifungal therapy: potential interactions with other classes of drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970250-3

7 January 2021

Current therapy of dermatophytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970250-3

7 January 2021

Lack of efficacy of 6-week treatment with oral terbinafine for tinea capitis due to Microsporum canis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970250-3

7 January 2021

Tinea capitis: itraconazole in Trichophyton tonsurans infection

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970250-3

7 January 2021

Treatment of kerion with fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970250-3

7 January 2021

Griseofulvin inhibits Fungal Mitosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970250-3

7 January 2021

Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970250-3

7 January 2021

Onychomycosis in children: prevalence and treatment strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970250-3

7 January 2021

An open clinical pilot study of the efficacy and safety of oral terbinafine in dry non-inflammatory tinea capitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970250-3

7 January 2021

Treatment of chronic dermatophyte infections. The use of ketoconazole in griseofulvin treatment failures

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970250-3

7 January 2021

Overview of the use of terbinafine (Lamisil) in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970250-3

7 January 2021

Randomized single-blind study of efficacy and tolerability of terbinafine in the treatment of tinea capitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970250-3

7 January 2021

Itraconazole in the treatment of tinea capitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970250-3

7 January 2021

Tinea capitis in California children: a population-based study of a growing epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970250-3

7 January 2021

Itraconazole versus griseofulvin in the treatment of tinea capitis: a double-blind randomized study in children

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970250-3

7 January 2021

Therapy with fluconazole for tinea corporis, tinea cruris, and tinea pedis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970250-3

7 January 2021

Pilot study of terbinafine in children suffering from tinea capitis: evaluation of efficacy, safety and pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970250-3

7 January 2021

Childhood white superficial onychomycosis caused by Trichophyton rubrum: report of seven cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970250-3

7 January 2021

Dermatophytomycoses in children in rural Kenya: the impact of primary health care

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970250-3

7 January 2021

Terbinafine: An oral and topical antifungal agent

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970250-3

7 January 2021

Fluconazole for the treatment of tinea capitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970250-3

7 January 2021

Medicine taking in Southampton: a second look

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970250-3

7 January 2021

Treating tinea capitis: should ketoconazole replace griseofulvin?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970250-3

7 January 2021

Terbinafine in onychomycosis of the toenail: A novel treatment protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970250-3

7 January 2021

Posttreatment itraconazole levels in the nail. New implications for treatment in onychomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970250-3

7 January 2021

Efficacy of a 1-week, once-daily regimen of terbinafine 1% cream in the treatment of tinea cruris and tinea corporis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970250-3

7 January 2021

The successful treatment of finger Trichophyton rubrum onychomycosis with oral terbinafine.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970250-3

7 January 2021

10.1016/S0733-8635(05)70250-3

Identifiers

DOI

1 reference

24 September 2017

1 reference